CME/CE

Episodes 181-195 of 745

• 

  RestartResume

  Identifying a Key Cause of Hard to Control Diabetes

  CME/CE

  Identifying a Key Cause of Hard to Control Diabetes

  • 

    

    Stephen Brunton, MD, FAAFP, CDCES

    Peer

  • 

    

    John Buse, MD, PhD

    Peer

  • 

    

    Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP

    Peer

  • 

    

    Eden Miller, DO, D-ACD, D-ABOM

    Peer

  1.00 credits

• 

  RestartResume

  Chairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach

  CME/CE

  Chairperson’s Perspective: Optimizing Perioperative Therapy in Early-Stage NSCLC: A Multidisciplinary Approach

  • 

    

    Heather Wakelee, MD, FASCO

    Peer

  0.25 credits

• 

  MinuteCE®

  Innovations in Oncology Learning Center: From Guidelines to Practice: Melanoma

  • 

    

    John M. Kirkwood, MD

    Peer

  • 

    

    Paolo A. Ascierto, MD

    Peer

  • 

    

    Hussein Tawbi, MD, PhD

    Peer

  • 

    

    Sapna Patel, MD

    Peer

  1.00 credits 10 episodes

• 

  MinuteCE®

  Reimagining Lung Cancer Treatment: A Journey Through New and Emerging Therapeutics Related to the Care of Patients with Small Cell and Non-Small Cell Lung Cancer

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 credits 9 episodes

• 

  RestartResume

  Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)

  MinuteCE®

  Updates in Limited-Stage Small Cell Lung Cancer (LS-SCLC)

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

  MinuteCE®

  Novel Therapies in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits
• advertisement

• 

  RestartResume

  Applications of Emerging Data in Resectable NSCLC

  MinuteCE®

  Applications of Emerging Data in Resectable NSCLC

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits

• 

  RestartResume

  The Current Therapeutic Landscape in Unresectable Stage III NSCLC

  MinuteCE®

  The Current Therapeutic Landscape in Unresectable Stage III NSCLC

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Strategies in EGFR-mutated Unresectable Stage III NSCLC

  MinuteCE®

  Strategies in EGFR-mutated Unresectable Stage III NSCLC

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC

  MinuteCE®

  Finding the Optimal Treatment for EGFR-mutated Metastatic NSCLC

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits

• 

  RestartResume

  HER2-Driven Strategies in Metastatic NSCLC

  MinuteCE®

  HER2-Driven Strategies in Metastatic NSCLC

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits

• 

  RestartResume

  MET and Other Emerging Targets in Metastatic NSCLC

  MinuteCE®

  MET and Other Emerging Targets in Metastatic NSCLC

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits
• advertisement

• 

  RestartResume

  Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC

  MinuteCE®

  Emerging Therapeutic Developments in Non-Targetable Metastatic NSCLC

  • 

    

    Stephen Liu, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  • 

    

    Susan Scott, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma

  MinuteCE®

  Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma

  • 

    

    John M. Kirkwood, MD

    Peer

  • 

    

    Sapna Patel, MD

    Peer

  1.00 program credits

• 

  RestartResume

  Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma

  MinuteCE®

  Clinical Implications of Neoadjuvant Therapy Guideline Updates in Resectable Melanoma

  • 

    

    John M. Kirkwood, MD

    Peer

  • 

    

    Sapna Patel, MD

    Peer

  1.00 program credits

• Prev
• 1
• 2
• …
• 11
• 12
• 13
• 14
• 15
• …
• 49
• 50
• Next